These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 8208326)

  • 21. Bone markers in osteoporosis and malignancy.
    Lipton A; Costa L; Demers LM
    Can J Oncol; 1995 Dec; 5 Suppl 1():11-5. PubMed ID: 8853519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The assessment of bone metabolism in vivo using biochemical approaches.
    Russell RG
    Horm Metab Res; 1997 Mar; 29(3):138-44. PubMed ID: 9137985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical markers of bone collagen type I metabolism.
    Zaitseva OV; Shandrenko SG; Veliky MM
    Ukr Biochem J; 2015; 87(1):21-32. PubMed ID: 26036128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical usefulness of bone turnover markers with the treatment of osteoporosis].
    Miura M
    Clin Calcium; 2014 Mar; 24(3):367-76. PubMed ID: 24576933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.
    Hannon R; Blumsohn A; Naylor K; Eastell R
    J Bone Miner Res; 1998 Jul; 13(7):1124-33. PubMed ID: 9661076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
    Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
    Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of bone health and osteoporosis risk.
    Eastell R; Hannon RA
    Proc Nutr Soc; 2008 May; 67(2):157-62. PubMed ID: 18412989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marker alterations in patients with type 1 Gaucher disease.
    Ciana G; Martini C; Leopaldi A; Tamaro G; Katouzian F; Ronfani L; Bembi B
    Calcif Tissue Int; 2003 Mar; 72(3):185-9. PubMed ID: 12522660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical markers of bone turnover in girls during puberty.
    Blumsohn A; Hannon RA; Wrate R; Barton J; al-Dehaimi AW; Colwell A; Eastell R
    Clin Endocrinol (Oxf); 1994 May; 40(5):663-70. PubMed ID: 7516828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical markers of bone turnover for the clinical assessment of bone metabolism.
    Taylor AK; Lueken SA; Libanati C; Baylink DJ
    Rheum Dis Clin North Am; 1994 Aug; 20(3):589-607. PubMed ID: 7984780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females.
    Weaver CM; Peacock M; Martin BR; McCabe GP; Zhao J; Smith DL; Wastney ME
    J Bone Miner Res; 1997 Oct; 12(10):1714-20. PubMed ID: 9333133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating biochemical markers of bone remodeling in uremic patients.
    Ureña P; De Vernejoul MC
    Kidney Int; 1999 Jun; 55(6):2141-56. PubMed ID: 10354264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
    Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
    Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prediction by early change of bone metabolic markers of the efficacy of anti-osteoporotic drugs on bone mass in osteoporotic patients].
    Inaba M
    Clin Calcium; 2014 Mar; 24(3):379-84. PubMed ID: 24576934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in markers of bone formation and resorption in a bed rest model of weightlessness.
    Lueken SA; Arnaud SB; Taylor AK; Baylink DJ
    J Bone Miner Res; 1993 Dec; 8(12):1433-8. PubMed ID: 8304043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early modifications of biochemical markers of bone metabolism in spinal cord injury patients. A preliminary study.
    Uebelhart D; Hartmann D; Vuagnat H; Castanier M; Hachen HJ; Chantraine A
    Scand J Rehabil Med; 1994 Dec; 26(4):197-202. PubMed ID: 7878394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemical markers for bone metabolism--overview].
    Nakatsuka K; Nishizawa Y
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():220-7. PubMed ID: 11979911
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
    Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.